This highlights the potential therapeutic implications of targeting HSPA8 to enhance autophagic processes and restore lipid balance, offering a promising avenue for intervention in Alzheimer’s disease. The gene discussed is HSPA8; the disease is early-onset autosomal dominant Alzheimer disease.